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ABSTRACT 
Introduction: Obesity is the main modifiable risk factor for the development of chronic diseases 
in Mexico. Several randomized controlled trials have shown that intensive lifestyle programs are 
efficacious for the management of obesity. These programs include frequent sessions (14 or more 
contacts in the first 6 months) focused on diet and physical activity and use a behavior change 
protocol. However, most Mexican primary care clinics and public hospitals apply traditional 
treatments for obesity management with limited results on weight loss. The purpose of the study 
is to evaluate the effectiveness of the Diabetes Prevention Program (DPP) "Group Lifestyle 
Balance" for weight loss among adults with overweight and obesity from baseline to 6 months 
and from baseline to 12 months in primary care clinics and public hospitals from Sonora, México 
Material and methods: This is a translational, multi-center, non-controlled, 6 and 12-month 
follow-up clinical study with a pre-test and post-test design. Healthcare providers from two 
primary care clinics, two hospitals and one university clinic will be trained with the DPP protocol 
to implement on their overweight and obese adult patients. Body weight, body mass index, waist 
circumference, systolic and diastolic blood pressure, depression, quality of life and stress scales 
will be measured in participants receiving the program at baseline, 6 and 12 months. 
Biochemical parameters will be measured at baseline and 12 months. The primary outcome is 
the change in body weight at 6 and 12 months.  Conclusions: This study will provide scientific 
evidence of the effectiveness of the DPP protocol as a model for obesity management in real 
world clinical practice among the adult Mexican population.  
Keywords: Diabetes Prevention Program; Translational Medical Research; Weight Loss; Obesity; 
Life Style; Health Knowledge, Attitudes, Practice.  
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RESUMEN 
Introducción: La obesidad es el principal factor de riesgo para el desarrollo de enfermedades 
crónicas en México. Varios ensayos clínicos controlados han mostrado que los programas 
intensivos de cambio de estilo de vida son eficaces para el manejo de obesidad. Estos programas 
incluyen sesiones frecuentes (14 o más los primeros 6 meses), centradas en hacer mejoras en la 
dieta y actividad física utilizando un protocolo de cambio de comportamiento. Sin embargo, la 
mayoría de clínicas de primer nivel y los hospitales públicos aplican tratamientos tradicionales 
para el manejo de obesidad que tienen resultados limitados. El propósito del estudio es evaluar 
la efectividad del Programa de Prevención de Diabetes “Grupo de Equilibrio de Estilo de Vida” 
sobre la pérdida de peso en adultos con sobrepeso y obesidad del inicio a 6 meses y del inicio a 
12 meses del seguimiento en clínicas de primer nivel y hospitales públicos de Sonora, México. 
Material y métodos: Este es un estudio clínico multicéntrico traslacional, no controlado con 
diseño pre y post-prueba  a  6 y 12 meses. Los proveedores de salud de 2 clínicas de primer nivel, 
2 hospitales públicos y una clínica universitaria serán entrenados con el protocolo del Programa 
de Prevención de Diabetes, para implementarlo en sus pacientes adultos con obesidad. Se 
medirá el peso corporal, índice de masa corporal, circunferencia de cintura, presión sistólica y 
diastólica, así como escalas de depresión, calidad de vida y estrés, al inicio, 6 y 12 meses. Los 
parámetros bioquímicos se medirán al inicio y a los 12 meses. La variable de desenlace primaria 
será el cambio de peso a 6 y 12 meses. Conclusiones: Este estudio proveerá evidencia científica 
de la efectividad del protocolo del Programa de Prevención de Diabetes como un modelo para el 
manejo de obesidad en adultos mexicanos en condiciones de la práctica clínica del mundo real. 
Palabras clave: Programa de Prevención de Diabetes; Investigación en Medicina Traslacional; 
Pérdida de Peso; Obesidad; Estilo de Vida; Conocimientos, Actitudes y Práctica en Salud.  
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TRIAL REGISTRATION 
Registry 
ClinicalTrials.gov: NCT02537704 
Data set 
See Table 1. 
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Table 1. Trial registration data. 
Data category Information 
Primary registry and trial 
identifying number 
ClinicalTrials.gov NCT02537704 
Date of registration in primary 
registry 
2 September, 2015 
Secondary identifying 
numbers 
ClinicalTrials.gov : DPPMEX-077 
Source(s) of monetary or 
material support 
University of Sonora 
Primary sponsor University of Sonora 
Secondary sponsor(s)  
Contact for public queries Dr. Rolando Giovanni Díaz Zavala 
Contact for scientific queries giovanni.diaz@unison.mx 
Public title Translational Study for Obesity Management in Mexican Adults Using the 
"Group Lifestyle Balance Program" (GLBOMEX) 
Scientific title Translational Study for Overweight and Obesity Management in Adults 
Using the "Group Lifestyle Balance Program" in Primary Care Clinics and 
Public Hospitals from Sonora, México 
Countries of recruitment México 
Health condition(s) or 
problem(s) studied 
Obesity 
Intervention(s) Experimental: Group Lifestyle Balance Program 
Participants will be assigned to an adaptation of the "Group Lifestyle 
Balance Program", a behavioral curriculum implemented in the Diabetes 
Prevention Program Study. The Group Lifestyle Balance Program will be 
provided weekly for the first 3.5 months, bi-weekly from 3.5 to 6 months 
and then monthly until 12 months. Health care providers will be trained 
for the implementation of the intervention. 
Additionally, participants will attend at least one monthly visit with a 
nutritionist (individually). 
The lifestyle objectives for participants will be as follows: 
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To lose 5-10% of initial weight through healthy eating. 
To do 150 minutes of physical activity each week. 
Key inclusion and exclusion 
criteria 
Inclusion Criteria: 
• Adults (>18 years of age and <65) 
• Overweight or obese (BMI >25 kg/m2 y <50 kg/m2) 
• Availability and motivation to attend the intervention program 
• Patients who would benefit from participating in the program 
according to the health providers 
• Signing an informed consent 
Exclusion Criteria: 
• Medical conditions affecting body weight significantly 
• Pregnancy or nursing 
• Bariatric surgery 
• Being unable to participate in regular moderate physical activity 
• Blood pressure >160 mm/Hg 
• HbA1c >9 
Study type Interventional 
Date of first enrolment September, 2015 
Target sample size 250 
Recruitment status (This study was ongoing, but not recruiting participants at the time of the 
submission of protocol). At this time, the status is completed 
(16/Nov/2017) 
Primary outcome(s) Change in body weight [ Time Frame: Change in body weight from 
baseline to 6 months and change in body weight from baseline to 12 
months ] 
Key secondary outcomes • Change in waist circumference [ Time Frame: Change in waist 
circumference from baseline to 6 months and change in waist 
circumference from baseline to 12 months ] 
• Change in body fat percentage [ Time Frame: Change in body fat 
percentage from baseline to 6 months and change in body fat 
percentage from baseline to 12 months ] 
• Change in the Beck Depression Inventory score 
[ Time Frame: Change in the Beck Depression Inventory score from 
baseline to 6 months and change in the Beck Depression Inventory 
score from baseline to 12 months ] 
• Change in the Short Form-36 Health Survey score 
[ Time Frame: Change in the Short Form-36 Health Survey score 
from baseline to 6 months and change in the SF-36 Health Survey 
score from baseline to 12 months ] 
• Change in the Perceived Stress Scale (PSS) -14 score 
[ Time Frame: Change in the Perceived Stress Scale (PSS) -14 score 
from baseline to 6 months and change in the Perceived Stress 
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Scale PSS-14 score from baseline to 12 months ] 
• Change in systolic and diastolic blood pressure 
[ Time Frame: Change in systolic and diastolic blood pressure from 
baseline to 6 months and change in systolic and diastolic blood 
pressure from baseline to 12 months ] 
• Change in fasting glucose [ Time Frame: Change in fasting glucose 
from baseline to 12 months ] 
• Change in total cholesterol [ Time Frame: Change in total 
cholesterol from baseline to 12 months ] 
• Change in LDL-cholesterol [ Time Frame: Change in LDL-
cholesterol from baseline to 12 months ] 
• Change in HDL-cholesterol [ Time Frame: Change in HDL-
cholesterol from baseline to 12 months ] 
• Change in triglycerides [ Time Frame: Change in triglycerides from 
baseline to 12 months ] 
• Change in fasting insulin [ Time Frame: Change in fasting insulin 
from baseline to 12 months ] 
• Change in HOMA-IR [ Time Frame: Change in HOMA-IR from 
baseline to 12 months ] 
• Change in liver enzymes [AST and ALT] [ Time Frame: Change in 
liver enzymes [AST and ALT] from baseline to 12 months ] 
 
PROTOCOL VERSION 
Issue date: 10-April-2015 (original) 
Protocol amendment number: 01 (20-April-2015) 
Primary reason for amendment: changes in Section “Methods” regarding including the blood 
sampling in the procedures. This change was suggested by the Department of Medicine and 
Health Sciences Research Bioethical Committee of the University of Sonora. 
Authors: RGDZ, BAG 
Revision chronology 
10-April-2015 Original 
20-April-2015 Protocol amendment number: 01. 
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FUNDING 
This study will be funded by the University of Sonora, who will provide all the materials for the 
study, consumables, teaching materials, manuals, biochemical reagents and stationery for 
patients and health providers. Additionally, CONACYT (Consejo Nacional de Ciencia y Tecnología) will 
fund scholarships for two master degree students. 
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INTRODUCTION 
Background and rationale 
The worldwide prevalence of obesity has increased in the last decades, including developing 
countries. According to the latest National Health and Nutrition Survey (ENSANUT 2012) in 
Mexico, the combined prevalence of overweight and obesity in adults was 71.3% (representing 
48.6 million people)1. Obesity is one of the major risk factors for type 2 diabetes and 
cardiovascular disease, the leading causes of death among Mexicans2. It is widely known that a 
reduction of 5% in body weight in patients with obesity leads to better glucose levels, plasmatic 
lipids, insulin sensitivity, decrease in blood pressure and other benefits3. 
The US Expert Panel on Obesity recently suggested intensive lifestyle programs as the gold 
standard for obesity management3. These programs consist of group and individual weekly visits 
(≥ 14 sessions in the first 6 months of treatment and then monthly) with a trained healthcare 
provider to achieve positive changes in diet, physical activity and body weight, using a behavior 
modification protocol based on a workshop manual3,4.  
Studies such as the Diabetes Prevention Program (DPP) and Action for Health in Diabetes – Look 
AHEAD – showed, in 2 multicenter clinical trials the possibility of adequate weight management 
through an intensive lifestyle program, using a behavior modification protocol: “Group Lifestyle 
Balance®”5,6. DPP participants lost on average 6.6% (7 kg) a year after treatment and sustained 
80% of the weight loss after 2.8 years5. There was a 58% reduction in the incidence of diabetes as 
well as other benefits compared to the control group5. The Look AHEAD study applied the same 
protocol as the DPP and observed similar results. There was an 8.7% weight loss a year after 
patients participated in the intensive lifestyle program, 4.7% weight loss four years after, and 
4.5% eight years after treatment6. Along with weight loss, patients in the intervention group 
exhibited higher diabetes remission7, plus improvement in risk factors for cardiovascular 
disease8, depression9, sleep apnea9, and urinary incontinence10 when compared to the control 
group. 
Most of the health centers, clinics and hospitals (public and private) in Mexico do not apply 
evidence-based programs such as the intensive lifestyle program defined above. These types of 
programs are not considered in policies or guidelines for obesity management in México11,12. 
Programs for obesity management usually consist of diet and physical activity recommendations 
given at monthly or quarterly visits with a doctor or a nutritionist (and sometimes 
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psychologists)13. When these strategies are tested in randomized controlled trials, results range 
from a reduction of 1.5 kg to an increase of 1 kg at one-year follow-up14-16.  
Since the general population frequently are not experiencing the benefits of treatments based on 
efficacy studies, several academic healthcare organizations and government agencies have 
prioritized translational research17. Translational research is defined as applied research that 
aims to translate available knowledge into clinical and public health practice. Several studies 
have applied the DPP protocol “Group Lifestyle Balance” in real world conditions. These studies 
have been implemented by diverse healthcare providers in different real world settings (primary 
healthcare, specialized units, churches, and other establishments) and have shown  variable but 
acceptable results (−2.7% to −6% body weight reduction and improvement in risk factors)17. 
However, evidence is limited, especially in developing countries such as Mexico.  
This research group recently observed, in a randomized controlled trial pilot study, that adult 
obesity control can be substantially improved in the primary care setting18. An adaptation of the 
DPP protocol was implemented, with 12 weekly group sessions; in addition to weekly visits with a 
nutritionist and meal replacements. The experimental group was compared against a traditional 
treatment (diet and physical activity recommendations given monthly by a nutritionist). After 
three months of treatment, the DPP protocol group had a weight loss of 4.7 kg against an 
increase of 0.4 kg in the traditional treatment group (P<0.001)18. Sixty-six percent of participants 
in the intervention group attained a reduction greater than 5% of initial body weight against 0% 
of the traditional treatment group. There were also significant decreases in body mass index, 
waist circumference, hip circumference, and percentage body fat18. 
Explanation for choice of comparators 
Given that this study attempted to evaluate the translation (dissemination) of a previously 
validated program into a real world clinical setting (instead of proving efficacy), the study did not 
include a control group.  Additionally, numerous studies have not observed important changes in 
the body weight of control group participants5,8,19, including one study implemented in México by 
our group that shows an increase in body weight18. Recently, Johns and colleagues evaluated the 
weight change of participants randomized to minimal intervention control groups in weight loss 
trials. The analysis included twenty-nine studies representing 5,963 individuals. They found that 
the weight loss at 12 months was minimal (-0.8 kg [95%CI: -1.1 to -0.4])20. Thus, considering the 
focus of the study and the evidence mentioned above, we considered a control group to be 
unnecessary. 
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Study objectives 
Primary Objective 
To evaluate the effectiveness of the Diabetes Prevention Program "Group Lifestyle Balance" for 
weight loss among adults with overweight and obesity from baseline to 6 months and from 
baseline to 12 months in primary care clinics and public hospitals from Sonora, Mexico 
Secondary objectives 
The key secondary objectives are to evaluate the effectiveness of the Diabetes Prevention 
Program "Group Lifestyle Balance" among adults with overweight and obesity for: 
● Change in waist circumference from baseline to 6 months and from baseline to 12 
months. 
● Change in body fat percentage from baseline to 6 months and from baseline to 
12 months. 
● Change in the Beck Depression Inventory from baseline to 6 months and from 
baseline to 12 months. 
● Change in the Short Form-36 Health Survey score from baseline to 6 months and 
from baseline to 12 months. 
● Change in the Perceived Stress Scale (PSS) -14 from baseline to 6 months and 
from baseline to 12 months. 
● Change in systolic and diastolic blood from baseline to 6 months and from 
baseline to 12 months. 
● Change in fasting glucose from baseline to 12 months. 
● Change in total cholesterol from baseline to 12 months. 
● Change in LDL-cholesterol from baseline to 12 months. 
● Change in HDL-cholesterol from baseline to 12 months. 
● Change in triglycerides from baseline to 12 months. 
● Change in fasting insulin from baseline to 12 months. 
● Change in HOMA-IR from baseline to 12 months. 
● Change in liver enzymes [AST and ALT] from baseline to 12 months. 
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Trial design 
This is a translational, multi-center, non-controlled, 6 and 12-month follow-up clinical study with 
a pre-test and post-test design. 
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MATERIAL AND METHODS  
Study setting 
Two public primary healthcare clinics will be included: Dr. Domingo Olivares Health Center and 
Advanced Primary Healthcare Center; two public hospitals: General Hospital of the State of 
Sonora and Dr. Ignacio Chávez Hospital; and a public university clinic in Hermosillo, Sonora: 
Nutrition Health Promotion Center at University of Sonora. Hermosillo is an urban city with 
884,273 inhabitants, located in the state of Sonora, northwest of Mexico. The effectiveness of the 
program in the different levels of healthcare will be evaluated. Relevant authorities from the 
state government Department of Health (heads of education, social service coordinators, heads 
of health centers, and officials responsible for obesity management in hospitals) will be invited to 
participate.  
 
Eligibility criteria 
All participants must accept and sign an informed consent form to participate in the study. 
Inclusion Criteria 
Healthcare providers will recruit patients following the inclusion criteria: adults (aged 18 to 65), 
with overweight or obesity (BMI: >25 kg/m2 to <50 kg/m2), who are motivated and available to 
attend the intervention program. Only patients who attend at least one individual consultation 
and a group session will be included. Contrary to efficacy trials, all patients considered to have 
the potential to benefit from the program through weight loss, healthy diet, and moderate 
physical activity will be included, even if they suffer from certain health conditions (hypothalamic 
obesity, hypothyroidism, Cushing syndrome, under medical treatment) or are taking medication 
(biguanides, sulfonylureas, etc.) affecting weight. People who are unable to read will be able to 
participate if they have a literate support person who can come along with them to the sessions. 
Exclusion Criteria 
Pregnant women or women who breastfed in the last 6 months, bariatric surgery, glycated 
hemoglobin > 9%, patients taking insulin, systolic blood pressure >160 mm/Hg, or patients who 
are negatively affected by weight loss or physical activity will be excluded.  
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Eligibility criteria for study centers and individuals who will perform the interventions 
The study will be divided into two phases.  In the first phase healthcare providers will be trained, 
and in the second phase program implementation and evaluation at 6 and 12 months will take 
place.  
The first phase will focus on training and standardization of healthcare providers (nutritionists, 
social service nutrition interns, and physicians) of participating clinics to implement the 
intervention program. Institutions interested in participating will need a designated area for 
patient consultation (including basic anthropometric equipment) and a classroom for group 
sessions. An essential requirement for the institutions will be to have a nutrition intern for 
nutritional counseling of the participants. In Mexico it is mandatory for nutrition students that at 
the end of their four-year academic formation, they conduct 1 year of social service in public 
health institutions without financial remuneration. This group represents a potential population 
of competent health providers at low cost for the dissemination of the program in the health 
sector in Mexico.  
Healthcare provider training 
The training course will last for 35 hours and include two modules. The first module will focus on 
clinical evaluation of the patient with obesity, covering topics like dietary management, etiology, 
diagnosis and treatment21, and will include study of recent scientific literature on updates and 
successful interventions, and the US guidelines for obesity management3-4,22,23. The second 
module will be dedicated to training the healthcare providers on an adaptation of the Diabetes 
Prevention Program protocol “Group Lifestyle Balance®” 
http://www.diabetesprevention.pitt.edu/index.php/for-the-public/group-lifestyle-balance-
materials/. The adapted manual is made up of 32 topics, divided into 25 sessions; with nutrition 
aspects, physical activity, and behavior strategies. Additionally, topics on standardization of 
anthropometric measurements will be included (Table 2).  
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Table 2. Healthcare Provider Training. 
Hours Topics 
 
 
5 
▪ Introduction to overweight and obesity management in adults with the 
“Lifestyle Balance” program in public clinics and hospitals in Sonora  
▪ Format utilization  
▪ Standardization of  anthropometric measurements 
 
5 
▪ Intensive lifestyle modification programs for obesity management. Why are 
these the gold standards in obesity management? (Results from the Diabetes 
Prevention Program (DPP); The Look AHEAD study; a Mexican translational study 
using the DPP; and US Guidelines (2014) for adult obesity management) 
▪ How to evaluate and treat the obese patient  
 
 
 
 
 
 
 
25 
Adaptation of the DPP protocol “Group Lifestyle Balance Program”® 
Session 1. “Welcome to the Lifestyle Balance Program®” 
Session 2. “Fat and calorie detective” 
Session 2.1 “Reading a nutrition label” 
Session 2.2 “Cooking demonstration” and “Food weighing”* 
Session 3. “Move those muscles” 
Session 4. “Food groups” and “Portion sizes”* 
Session 5. “Healthy eating” and “Calorie balance tilting” 
Session 6. “Take control of what is around you” 
Session 7. “How to design your own menu (Mexican System for Food Equivalents)”* 
Session 8. “Problem solving” 
Session 9. “Four key points to eating out healthily” and “The slippery path to lifestyle 
change” 
Session 10. “Make social signs work in your favor” and “Activity plan kickoff” 
Session 11. “You can manage your stress” 
Session 12. “How to feel motivated” 
Session 13. “Obesity risks”* 
Session 14. “Diabetes prevention”* 
Session 15.1 “Heart health and cholesterol”* 
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Session 15.2 “Heart health and hypertension”* 
Session 16. “Relationship between obesity and cancer” * 
Session 17. “Getting ready for long-term self-control” and “Adjust your thoughts for 
long-term self-control” 
Session 18. “More volume, less calories” and “Conscious eating” 
Session 19. “Strengthen your exercise program” 
Session 20. “Stretching: the truth about flexibility” 
Session 21. “Rise for your health” 
Session 22. “Looking at the past and looking at the future” 
* Additional session to the original program. 
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The providers will be handed a file with color-printed materials: Patient manual (Spanish version) 
and Provider manual (Spanish version, adapted by our research group) to work with during the 
program. Formats to register measurements of the study variables (weight, height, waist 
circumference, and blood pressure), formats for follow-up, attendance lists for patients, a 
chronogram of activities and additional material will also be supplied.  
Healthcare providers must attend every single training course session. The research group will 
have frequent contact with the participating healthcare providers. The training team will consist 
of three health professionals: one of them with a PhD in Science (GD-Z) and two Nutritional 
Sciences graduates with experience using the DPP protocol (BA-G and TM-C). 
 
Interventions 
Interventions 
The Intensive Lifestyle Intervention Program 
The intervention program will last for a year, the first three and half months will be intensive; 
patients will attend weekly group sessions (14 sessions), and at least one individual session but 
up to four individual sessions per month (depending on the healthcare provider and patient 
agreement and within the available time and space at the clinic). During months 3.5 to 6 the 
intervention will be less intensive with one group session every 2 weeks (5 sessions) and one 
individual session every month. After 6 months, group sessions and individual sessions will be 
scheduled once a month. The goal for each participant will be to lose 10% of initial body weight. 
Behavior change protocol (group sessions). Each participant will be handed an adaptation of the DPP 
protocol “Group Lifestyle Balance” manual, which includes topics such as weight loss and healthy 
lifestyle benefits, learning healthy eating, physical activity and active lifestyle benefits, calorie 
intake and balance, stimulus control training, problem solving strategies, assertive thinking and 
communication, control of negative thoughts, relapse and solutions, stress management, self-
control techniques, self-motivation, positive reinforcement, etc. (Table 2).  
The original “Group Lifestyle Balance” Patient manual and the Provider manual were adapted 
(original versions available for free on http://www.diabetesprevention.pitt.edu/index.php/for-the-
public/group-lifestyle-balance-materials/ We added topics on: “Cooking demonstration” and 
“Food weighing”, “Food groups” and “Portion sizes”, “How to design your own menu (Mexican 
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System for Food Equivalents)”, “Obesity risks”, “Diabetes prevention”, “Heart health and 
cholesterol”, “Heart health and hypertension” and “Relationship between obesity and cancer”. 
Cultural adjustments were also made to the content to fit the Mexican context.  For example, we 
used the Mexican System for Food Equivalents for nutrition prescriptions because nutrition 
interns are familiar with its use and it includes typical food for Mexico.  Likewise, most dynamics 
employed in the group sessions were developed by the research group. 
Participants will gradually aim for 150 minutes (2.5 hours) per week of physical activity, as well as 
a reduction in fat intake (33-55 g, depending on the participant’s baseline weight). 
Individualized nutrition session. The first weekly session with the healthcare provider will last 
between 40 to 60 minutes; subsequent sessions will be 20 to 30 minutes long. A medical history 
that includes dietary evaluation, anthropometry, biochemistry results and physical activity will be 
completed for each participant. Total energy expenditure (TEE) will be estimated and their diet 
restricted by 500 to 1000 kcal. 
Calorie intake will range from 1200-1800 kcal/day (depending on each participant’s TEE); 
macronutrient distribution as follows: 55% carbohydrate, 20% protein, and 25% lipids24. Meal 
replacements will be recommended as a substitute for 2 meals each day (breakfast and dinner); 
these will be used to improve weight loss25. In Mexico, the midday meal is the main meal of the 
day. Whole meal plans will be given to participants for the second month. During the third 
month, patients will be taught to create their own meal plan using a food exchange system26.  
         Patients will be able to buy commercial meal replacements (a product used in previous 
studies will be recommended8) or make a milkshake at home (milk, fruit, nuts, and 5 g of 
psyllium fiber). Patients will also be given the option of choosing a meal plan elaborated by a 
nutritionist if they do not want to take meal replacements.  
Modifications 
Participants who become pregnant during the intervention period, initiate other weight control 
treatment, or withdraw their informed consent will be excluded from the study. 
Adherence 
During each individual session, weight, goal progress, adherence to the meal plan, and adverse 
signs and symptoms will be checked and questions answered. Daily food intake and physical 
activity (minutes) recording will be recommended for each patient. If the participant is not able to 
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attend a group or individual session, a call will be made to schedule the next appointment. A roll 
call will be made in all group sessions. Telephone calls will be made by the coordinating center 
when patients do not attend more than two sessions or follow-up consultations. 
Concomitant care 
Patients will not be prohibited from any treatment that benefits their health; however those that 
can have a significant effect on body weight will be recorded. 
 
Outcomes 
The primary outcome will be the mean change in body weight from baseline to 6 months, and 
from baseline to 12 months. 
Secondary outcomes will include mean changes in other obesity parameters (waist 
circumference, body fat percentage), systolic and diastolic blood pressure, mental health 
measurements (depression, health-related quality of life, and perceived stress) from baseline to 6 
months and from baseline to 12 months, in addition to changes in biochemical parameters 
(fasting glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, fasting insulin, 
HOMA-IR, AST and ALT) from baseline to 12 months. 
 
Participant timeline 
See Figure 1. 
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Figure 1.  Schedule and duration of study time periods. 
 STUDY PERIOD 
 Screening 
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Assessment Treatment (months 1-6) 
Middle 
Assessment Treatment (months 7-12) 
Final 
Assessment 
MONTH -1 0 1 2 3 4 5 6 6 7 8 9 10 11 12 12 
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X 
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 X      
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Medication]  X      
 X 
 
     
X 
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X 
     
 X 
 
     X 
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X 
     
 X 
 
     X 
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X 
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     X 
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Sample size 
Group sample sizes were determined based on the main objective of this study, which is to determine 
changes in body weight from baseline to follow-up using a paired mean test. For that reason, group 
sample sizes were obtained through a paired t-test formula, considering data from a previous one 
year study with a mean weight loss of 4.2 kg and a standard deviation of 5.627.  In this way, using a 
two-tailed paired t-test, a significance level of 0.05 and power of 0.8, a sample size of 14 participants 
for each center28 was obtained. However, to allow for dropouts and the translational focus of the 
study, 50 subjects per center will be recruited (5 centers in total). This increase guarantees that group 
samples sizes will be also adequate for other exploratory comparisons. 
 
Recruitment 
Posters, flyers, Facebook page, direct invitation from nutritionists or social service nutrition interns, 
doctor and nurse referrals will be used to invite participants into the study. Meetings will take place to 
inform interested patients. Once patients are recruited in each clinic, they will be divided into groups 
of 25 to 50 people for the group sessions. 
 
Data collection methods 
Study measurements will take place during months 0, 6 and 12 in the Nutrition Health Promotion 
Center at the University of Sonora. 
Primary outcome 
Weight will be collected using standard techniques29; with a SECA MBCA (Medical Body Composition 
Analyzer, SECA Gmbh & Co. Kg Hammer Steindamm 9-25). 
Anthropometric and Body Composition measurements  
Height will be measured using a SECA stadiometer, model 284 (Seca Gmbh & Co. Hammer 
Steindamm 9-25, Germany; capacity 30-220 cm) with the participant in the Frankfort Plane, without 
shoes and facing forward25. Waist circumference will be measured at umbilical level29 with a fiberglass 
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anthropometric tape (GÜLICK, 0 to 150 cm). Fat percentage will be estimated by SECA MBCA (Medical 
Body Composition Analyzer, SECA Gmbh & Co. Kg Hammer Steindamm 9-25). A digital 
sphygmomanometer (Omrom, model HEM-907XL) will be used to measure systolic and diastolic blood 
pressure in duplicate30.  
Biochemical parameters 
A comprehensive assessment and evaluation of the effect of weight loss on biochemical parameters 
will be measured following standardized techniques: fasting glucose, total cholesterol, LDL-
cholesterol, HDL-cholesterol, triglycerides, aspartate aminotransferase (AST), alanine-
aminotransferase (ALT). Fasting insulin will be used as a marker for insulin resistance (HOMA-IR)31. 
Venous blood sampling and analysis will be performed at the Clinical Biochemistry Laboratory of 
Medicine at the University of Sonora. 
Mental health measurements 
To evaluate psychological variables, the participants will answer three questionnaires. The 
questionnaires will be administered by staff with the support of a psychologist with expertise in the 
area. The Beck Depression Inventory will be used to assess the effect of the program on depression32 
and health-related quality of life (HRQOL) will be evaluated with the SF-36 health survey33. To 
measure the effect of the program on stress, the Perceived Stress Scale, PSS-1434 will be applied. 
Retention 
Phone calls will be made when patients miss more than two consecutive sessions. No economic 
incentive will be given to patients for attending the 6 and 12 month measurements. In order to have 
the largest amount of data from the participants for the analysis, those who decide to leave the 
intervention will still be asked to attend the 6 and 12 month measurements with the purpose of 
obtaining the primary variable of the study (to allow and intention-to-treat analysis). 
Participant Withdrawal 
Participants may withdraw from the study at any time they wish. Participants will be withdrawn from 
the study if they become pregnant within the period of the study or if they start an alternative 
treatment for weight loss. 
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Data management 
In order to have quality data, double verification will be carried out by the study staff. The plausibility 
of the data will also be checked and any outlier will be carefully reviewed. 
Cost of the program  
Participating patients will not pay for the program (patient manual and materials for educational 
sessions) or individualized nutrition sessions in any of the centers but will be responsible for buying 
the meal replacements (if they choose them) and any food consumed at home. Health providers will 
not pay any cost for the training, materials, etc. 
 
Statistical methods 
Data will be presented as mean and standard deviation (mean ± SD) for normally distributed 
variables, and medians and percentiles (25-75) will be used for variables with a non-normal 
distribution. A paired t test (or Wilcoxon rank-sum test in the case of a non-normal distribution) will be 
used to evaluate the change from baseline to follow-up in the primary outcome (weight) and 
secondary variables (BMI, blood pressure, etc.) for each center. The primary and secondary outcomes 
at 6 and 12 months will be analyzed using completers and also by intention-to-treat analysis. We will 
make an effort to obtain the outcome measurements at 6 and 12 months for all participants who 
dropped out of the study to include these data in the intention-to-treat analysis. For subjects not 
participating in the 6 and 12 month measurements the baseline value will be used (baseline value 
carried forward) for the intention-to-treat analysis. We will perform some exploratory subgroup 
analysis to assess the effect of sex, age group, income, attendance at visits, diabetes status, obesity 
category, use of medications affecting weight, on the primary outcome. We will also evaluate if there 
are differences (at 6 and 12 months from baseline) between centers using one way ANOVA or Kruskal-
Wallis test (with Bonferroni or Dunn´s post hoc analyses) for normal or non-normal distributed 
continuous variables and chi-square (χ2) analyses for categorical variables with Bonferroni post hoc 
test. A p value < 0.05 from a two-tailed test will be used as a criterion for statistical significance (p 
Rev Esp Nutr Hum Diet. 2017; 21(4).  Freely available online - OPEN ACCESS 
doi: 10.14306/renhyd.21.4.391 [ahead of print] 
4 
 
value ≤ 0.05). Statistical software NCSS 10 will be utilized to analyze data (Number Cruncher 
Statistical System for Windows, Kaysville, UT, USA). 
 
Data monitoring 
This study does not have an external data monitoring committee. The progress of the study will be 
presented every six months to the group of researchers participating in the study. Also, once the final 
evaluations of the study are concluded, the results will be presented to the Department of Medicine 
and Health Sciences Research Bioethical Committee of the University of Sonora and to the Medical 
Center "Dr. Ignacio Chavez" Research Committee at ISSSTESON). No interim analysis is programmed 
for this study. 
 
Harms 
This section was not considered in the protocol, but this kind of intervention is considered as very low 
risk. 
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DISCUSSION  
To our knowledge this trial will be the first to present scientific evidence on the implementation of a 
translational study in a developing country. This study will open up opportunities to improve clinical 
practice in México and other developing countries.  
Some studies where the DPP protocol is implemented in real life conditions have had positive results 
(6.9 kg in a year)35, similar to those observed in efficacy studies (approximately 7 kg in a year)5. 
Nonetheless, there have been interventions with less favorable results (0.45 kg to 3.3 kg in weight 
loss)36,37; making it crucial to have a protocol which is specific to the country’s culture and healthcare 
system.  
The study’s strengths include its translational approach. An evaluation connected to real world 
conditions will take place, including possible problems attached to clinical practice in public settings, 
such as high patient flow, lack of space, infrastructure and personnel, high activity demand, 
resistance to change, help of students in training (nutrition interns), etc. Several public clinics are 
included and the study sample was estimated to detect changes in body weight in each clinic, making 
it possible to evaluate the effect of the program at different levels of healthcare. Healthcare providers 
participating will be nutrition interns with no previous experience in obesity management; meaning 
optimal generalization of results. 
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ETHICS AND DISSEMINATION 
Research ethics approval 
The present protocol was approved by the Department of Medicine and Health Sciences Research 
Bioethical Committee of the University of Sonora (2015-Apr-10) and by the Medical Center "Dr. 
Ignacio Chavez" Research Committee at ISSSTESON (CEI-015-2015). 
Health care professionals from the medical centers and clinics, patients and other relevant groups 
will be informed about the results of this trial. Additionally, the findings of this study will be presented 
at relevant academic congresses and published in peer-reviewed journals. 
 
Consent or assent 
Participants will receive information about the study by health providers in the clinics. Additionally, 
the research staff will ensure the understanding of the study and ask the participants to sign a 
consent form. 
 
Confidentiality 
All the participants’ information will be protected under identification codes and stored in both 
physical and electronical forms. Study investigators will have full access to the data.  
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